SCHRODER INVESTMENT MANAGEMENT GROUP - SORRENTO THERAPEUTICS INC ownership

SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 217 filers reported holding SORRENTO THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.

Quarter-by-quarter ownership
SCHRODER INVESTMENT MANAGEMENT GROUP ownership history of SORRENTO THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$1,736,000
-68.2%
373,382
-47.8%
0.00%
-75.0%
Q3 2021$5,454,000
-34.4%
714,821
-16.6%
0.01%
-20.0%
Q2 2021$8,308,000
+132.9%
857,297
+98.8%
0.01%
+100.0%
Q1 2021$3,567,000431,2380.01%
Other shareholders
SORRENTO THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 5,000,000$9,200,0000.43%
SABBY MANAGEMENT, LLC 287,386$529,0000.22%
Virtus ETF Advisers LLC 88,342$163,0000.07%
Donald L. Hagan, LLC 26,002$67,0000.06%
MinichMacGregor Wealth Management, LLC 26,002$67,0000.06%
Pegasus Asset Management, Inc. 15,000$28,0000.02%
MATRIX ASSET ADVISORS INC/NY 50,000$92,0000.02%
S&T BANK/PA 38,853$71,0000.02%
Integrated Wealth Concepts LLC 108,391$199,0000.02%
Kore Private Wealth LLC 37,302$69,0000.02%
View complete list of SORRENTO THERAPEUTICS INC shareholders